Estimated Risks in England for 60+ Age Group January 2022 to May 2022

August 11 2022

Image 1. Raw Death Counts for England

[https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsinvolvingcovid19byvaccinationstatusengland/deathsoccurringbetween1january2021and31may2022]

In Image 1, note that the risk for the EverVax steeply increased after receiving the 3rd dose such that by April 2022 in the 70 + age group the risks increased by 90% or higher. In other words over 90% of the total risk is attributable to the 3rd dose. This clearly indicates the third dose of the mRNA vaccines is very toxic causing death and also contributes to deaths with SARS-CoV-2 infection. This may help explain why deaths such as in hospitals for the omicron variants more frequently did not appear to involve COVID-19.

The risks of the COVID-19 mRNA vaccines themselves in causing death have been grossly underestimated due to insufficient duration of RCTs and lack of data regarding 3rd doses in the elderly. The regulatory authorities, the advisory committee members, public health authorities and the manufacturers must be held accountable.

Booster doses appear to provide a substantial increase in mortality risks with the mRNA COVID-19 vaccines.

Note (data not captured in Image 1) that the administration of the first dose in January 2021 resulted in significant transmission of SARS-CoV-2 at the time of first immunization such that the COVID-19 deaths <21 days to deaths >21 days ratios were by age group:

• 90+ 862/364

• 80-89 1129/576

• 70-79 307/70

• 60-69 62/10

For the third dose the raw death counts at <21 days to deaths >21 days ratios were for COVID-19 deaths in October 2021 by age group:

• 90+ 40/8

• 80-89 69/12

• 70-79 25/5

• 60-69 5/<3

In the UK the second dose was delayed up to 12 weeks due to limited supply and thus, the second dose was provided in January 2021 to the 90+ and 80-89 year olds such that the ratios of COVID-19 death counts <21 days to >21 days were:

• 90 + 16/5

• 80-89 49/6

The same for the 70-79 year olds was for April: 8/6 and for May for the 60-69 year olds was: 4/<3.

Altogether these results illuminate the hazards of attendance of vaccination clinics especially for the first dose in the elderly at either nursing homes or at large clinics during lock-downs and would be consistent with incomplete protection by the wearing of flimsy masks.

Image 2. ENGLAND Actual 60+ Population Vaccinated with 3rd Dose and Calculation of Unvaccinated 60+ Population

The numbers changed slightly for the week 27 versus the week 22 reports due to people aging and/or deaths.

Selected the week 22 reports as closer to the end of the period of interest ending May 31, 2022.

Image 3. Calculation of Vaccinated to Unvaccinated Risk and Risk Factor for 60+ Years of Age for January 2022 to May 2022 for (above) for all deaths including the third dose and (below) for only the third dose deaths.

All Vaccine Deaths Included

The risk for COVID-19 deaths was 1/1362 for unvaccinated versus 1/987 for vaccinated for all deaths with a risk factor of 1.38.

The risks for non-COVID-19 deaths was 1/350 for unvaccinated versus 1/88 for vaccinated for all deaths with a risk factor of 3.98.

For Just the 3rd Dose Vaccine Deaths Included

The risk for COVID-19 deaths was 1/1362 for unvaccinated versus 1/1204 for vaccinated for all deaths with a risk factor of 1.13.

The risks for non-COVID-19 deaths was 1/350 for unvaccinated versus 1/99 for vaccinated for all deaths with a risk factor of 3.54.

Clearly the vast majority of the risks is derived from the 3rd dose (the first booster given approximately in October 2021). Some have now received the second booster.

The risk of death from 3 doses of mRNA vaccines (potentially with omicron exposures) is about 1/88 for the 60 + population. It would be higher for the 80+ population (Image 4) about 1/29. Note that this number includes all non-COVID-19 deaths including those induced by vaccination.

Image 4. Risks for the 80+ Group

Image 5. UKHSA claims insufficient data to calculate Mortality risks of Pfizer mRNA vaccine by week 31, 2022.

These vaccines are providing no benefit (likely harm) and a significant risk of mRNA vaccine death in the 60 + age group.